Beta
Back to UNH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
cash-and-debt-chart

UNH Cash & Debt

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q1'26, UnitedHealth Group (UNH) reported cash and short-term investments at $31.2B USD, marking a moderate increase from $28.1B in Q4'25 but remaining below the series peak of $46.3B in Q2'23. In contrast, total debt stood at $77.9B USD, showing a slight decline from $78.4B in the prior quarter and stabilizing after peaking at $81.3B in Q1'25. This latest snapshot highlights a net debt position of approximately $46.7B, reflecting ongoing liquidity management amid rising operational demands. Over the period from Q2'23 to Q1'26, cash and short-term investments exhibited volatility with an overall downward trend, declining from $46.3B to $31.2B—a net drop of about 33%—driven by sharp falls in Q4'23 ($29.6B) and Q4'24 ($29.1B), interspersed with partial recoveries in Q3'24 ($37.1B) and Q1'25 ($34.3B). Debt levels trended upward overall, rising from $65.6B to $77.9B (a 19% increase), with notable accelerations in Q1'24 ($73.6B) and Q1'25 ($81.3B), though moderated by minor reductions in recent quarters like Q4'25. The bar chart underscores a persistent debt burden outpacing cash reserves, suggesting potential leverage risks despite intermittent liquidity improvements, warranting close monitoring for financial stability.